Barclays PLC Neurocrine Biosciences Inc Call Options Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $7.85 Million - $8.59 Million	60,000 New	60,000 $8.26 Million
Q2 2020 Aug 12, 2020	SELL	$85.09 - $130.36 $1.72 Million - $2.63 Million	-20,200 Reduced 93.52%	1,400 $171,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $6.61 Million - $10 Million	-88,000 Reduced 80.29%	21,600 $1.87 Million
Q4 2019 Feb 10, 2020	BUY	$86.8 - $118.57 $8.19 Million - $11.2 Million	94,300 Added 616.34%	109,600 $11.8 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $83,820 - $101,500	1,000 Added 6.99%	15,300 $1.38 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $395,067 - $521,721	5,700 Added 66.28%	14,300 $1.26 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $3.03 Million - $5.51 Million	-44,300 Reduced 83.74%	8,600 $614,000
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $415,296 - $528,570	4,200 Added 8.62%	52,900 $6.5 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $421,680 - $593,544	-5,600 Reduced 10.31%	48,700 $4.78 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $1.05 Million - $1.28 Million	13,900 Added 34.41%	54,300 $4.5 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $81,942 - $108,626	-1,400 Reduced 3.35%	40,400 $3.13 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $2.01 Million - $2.56 Million	41,800	41,800 $2.56 Million

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.